|
|
Etude de phase II sur l’efficacité et la tolérance d’une augmentation de dose de radiothérapie des lésions hypoxiques définies par TEP-scanographie au fluoromisonidazole chez les patients suivis pour un cancer bronchique non à petites cellules
Sébastien Thureau
,
Philippe Chaumet Riffaud
,
Romain Modzelewski
,
Sébastien Hapdey
,
Marc Mahé
,
et al.
Congrès de la Société Française de Radiothérapie et Oncologie, 2016, Paris, France
Conference poster
hal-01665300v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Characterisation of heterozygous PMS2 variants in French patients with Lynch syndrome
Qing Wang
,
Julie Leclerc
,
Gaëlle Bougeard
,
Sylviane Olschwang
,
Stéphanie Vasseur
,
et al.
Journal articles
hal-02460716v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Performance of CT Compared with F-FDG PET in Predicting the Efficacy of Nivolumab in Relapsed or Refractory Hodgkin Lymphoma
Fatima-Zohra Mokrane
,
Aiping Chen
,
Lawrence H Schwartz
,
Franck Morschhauser
,
Apasia Stamatoullas
,
et al.
Journal articles
hal-02569415v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
French ccAFU guidelines - Update 2018-2020 Prostate cancer
F. Rozet
,
C. Hennequin
,
J-B Beauval
,
P. Beuzeboc
,
L. Cormier
,
et al.
Journal articles
hal-01978475v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Correction to A Novel Covalent mTOR Inhibitor, DHM25, Shows in Vivo Antitumor Activity against Triple-Negative Breast Cancer Cells
Amélie Fouqué
,
Olivier Delalande
,
Mickael Jean
,
Rémy Castellano
,
Emmanuelle Josselin
,
et al.
Journal articles
hal-02526957v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Bendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter study.
Emilie Reboursiere
,
Fabien Le Bras
,
Charles Herbaux
,
Emmanuel Gyan
,
Aline Clavert
,
et al.
Journal articles
hal-01475957v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Recommandations françaises du Comité de Cancérologie de l’AFU – Actualisation 2018–2020 : cancer de la prostate
F. Rozet
,
C. Hennequin
,
J.-B. Beauval
,
P. Beuzeboc
,
L. Cormier
,
et al.
Journal articles
hal-02281703v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Phase II study of bendamustine, bortezomib and dexamethasone as second-line treatment for elderly patients with multiple myeloma: the Intergroupe Francophone du Myelome 2009-01 trial
P. Rodon
,
C. Hulin
,
B. Pegourie
,
M. Tiab
,
B. Anglaret
,
et al.
Journal articles
hal-01116536v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Impact of body mass index on overall survival in patients with metastatic breast cancer
Khalil Saleh
,
Matthieu Carton
,
Véronique Dieras
,
Pierre-Etienne Heudel
,
Etienne Brain
,
et al.
Journal articles
hal-03345238v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Les points chauds de l’actualité en 2017. Une sélection du comité de rédaction du Bulletin du Cancer
Stéphane Vignot
,
Thierry André
,
Christophe Caux
,
Carole Bouleuc
,
Serge Evrard
,
et al.
Journal articles
hal-01712424v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Efficacy of chemotherapy or chemo-anti-PD-1 combination after failed anti-PD-1 therapy for relapsed and refractory hodgkin lymphoma: A series from lysa centers
Cédric Rossi
,
Julia Gilhodes
,
Marie Maerevoet
,
Charles Herbaux
,
Franck Morschhauser
,
et al.
Journal articles
hal-02050402v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Effect of Interval (7 or 11 weeks) Between Neoadjuvant Radiochemotherapy and Surgery on Complete Pathologic Response in Rectal Cancer: A Multicenter, Randomized, Controlled Trial (GRECCAR-6)
Jérémie H. Lefevre
,
Laurent Mineur
,
Salma Kotti
,
Eric Rullier
,
Philippe Rouanet
,
et al.
Journal articles
hal-01903754v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib
Nicolas Penel
,
Olivier Mir
,
Jennifer Wallet
,
Isabelle Ray-Coquard
,
Axel Le Cesne
,
et al.
Journal articles
hal-03623680v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Pancreatic cancer: French clinical practice guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, AFC)
Cindy Neuzillet
,
Sebastien Gaujoux
,
Nicolas Williet
,
Jean-Baptiste Bachet
,
Lucile Bauguion
,
et al.
Journal articles
hal-02143547v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL.
Camille Laurent
,
Alina Nicolae
,
Cecile Laurent
,
Fabien Le Bras
,
Corinne Haioun
,
et al.
Journal articles
hal-02529694v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Quelle vision des biomarqueurs en 2017 ? Promesses et défis de la médecine personnalisée en oncologie
Ronan Flippot
,
Christophe Massard
,
Édouard Auclin
,
David Azria
,
Heloise Bourien
,
et al.
Journal articles
hal-02370054v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Standard or accelerated methotrexate, vinblastine, doxorubicin and cisplatin as neoadjuvant chemotherapy for locally advanced urothelial bladder cancer: Does dose intensity matter?
Damien Pouessel
,
Sylvie Chevret
,
Frédéric Rolland
,
Gwenaëlle Gravis
,
Lionel Geoffrois
,
et al.
Journal articles
hal-01278607v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Genomic testing among patients with newly diagnosed advanced non-small cell lung cancer in the United States: A contemporary clinical practice patterns study
Luis Paz-Ares
,
Adam Gondos
,
Diego Saldana
,
Marlene Thomas
,
Céline Mascaux
,
et al.
Journal articles
hal-04085318v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Manufacture of adoptive cell therapies at academic cancer centers: scientific, safety and regulatory challenges
K. S. Saini
,
I. M. Svane
,
M. Juan
,
F. Barlesi
,
F. Andre
Journal articles
hal-04085346v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Preparation of thiophenepropenamide derivatives as flavivirus inhibitors in treatment of viral infections
Karine Barral
,
Jean Claude Guillemot
,
Bruno Canard
,
Gilles Quérat
,
Karine Alvarez
,
et al.
France, Patent n° : WO 2017102014. 2017
Patents
hal-02063286v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Combining systemic and locally applied cellular therapies for the treatment of systemic sclerosis
Mélanie Velier
,
Aurélie Daumas
,
Stéphanie Simoncini
,
Robin Arcani
,
Jérémy Magalon
,
et al.
Journal articles
hal-03777104v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
PDL1 expression is a poor-prognosis factor in soft-tissue sarcomas
François Bertucci
,
Pascal Finetti
,
Delphine Perrot
,
Agnès Leroux
,
Françoise Collin
,
et al.
Journal articles
hal-01765418v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Cost Analysis of Human Genome Sequencing in Cancer Diagnosis in France: Next Generation Sequencing
Dede Sika Kossi
,
Rajae Touzani
,
Isabelle Borget
,
Zhaomin Zou
,
Dominique Vaur
,
et al.
ISPOR 19th Annual European Congress, Oct 2016, Vienne, Austria. pp.A693
Conference papers
halshs-01446644v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Health-related quality of life results from the PRODIGE 5/ACCORD 17 randomised trial of FOLFOX versus fluorouracil–cisplatin regimen in oesophageal cancer
C. Bascoul-Mollevi
,
S. Gourgou
,
M.-P. Galais
,
J.-L. Raoul
,
O. Bouche
,
et al.
Journal articles
hal-01688845v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Chemotherapy for Muscle-invasive Bladder Cancer: Impact of Cisplatin Delivery on Renal Function and Local Control Rate in the Randomized Phase III VESPER (GETUG-AFU V05) Trial
Stéphane Culine
,
Valentin Harter
,
Gwenaelle Gravis
,
Aude Fléchon
,
Christine Chevreau
,
et al.
Journal articles
hal-03625944v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Therapy-related myeloid neoplasms following treatment with PARP inhibitors: new molecular insights
J.E. Martin
,
S. Khalife-Hachem
,
T. Grinda
,
M. Kfoury
,
S. Garciaz
,
et al.
Journal articles
hal-03623367v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
[2021 update of the GEFPICS’ recommendations for HER2 status assessment in invasive breast cancer in France]
Camille Franchet
,
Lounes Djerroudi
,
Aurélie Maran-Gonzalez
,
Olivia Abramovici
,
Martine Antoine
,
et al.
Journal articles
hal-03333764v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Functional status in older patients with cancer
Anne-Laure Couderc
,
Pierre Suchon
,
Bérengère Saliba-Serre
,
Dominique Rey
,
Emilie Nouguerede
,
et al.
Journal articles
hal-03585184v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Functional status in older patients with lung cancer: an observational cohort study
Anne-Laure Couderc
,
Pascale Tomasini
,
Laurent Greillier
,
Emilie Nouguerède
,
Dominique Rey
,
et al.
Journal articles
hal-03585187v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial
François Bertucci
,
Anthony Gonçalves
,
Arnaud Guille
,
José Adelaïde
,
Séverine Garnier
,
et al.
Journal articles
hal-03583277v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|